PL3286198T3 - Związki do leczenia stanów świądowych - Google Patents

Związki do leczenia stanów świądowych

Info

Publication number
PL3286198T3
PL3286198T3 PL16784019T PL16784019T PL3286198T3 PL 3286198 T3 PL3286198 T3 PL 3286198T3 PL 16784019 T PL16784019 T PL 16784019T PL 16784019 T PL16784019 T PL 16784019T PL 3286198 T3 PL3286198 T3 PL 3286198T3
Authority
PL
Poland
Prior art keywords
compounds
pruritic conditions
treating pruritic
treating
conditions
Prior art date
Application number
PL16784019T
Other languages
English (en)
Inventor
Amale Hawi
Original Assignee
Trevi Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trevi Therapeutics, Inc. filed Critical Trevi Therapeutics, Inc.
Publication of PL3286198T3 publication Critical patent/PL3286198T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PL16784019T 2015-04-23 2016-04-22 Związki do leczenia stanów świądowych PL3286198T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562151618P 2015-04-23 2015-04-23
PCT/US2016/029024 WO2016172613A1 (en) 2015-04-23 2016-04-22 Compounds for treating pruritic conditions
EP16784019.8A EP3286198B1 (en) 2015-04-23 2016-04-22 Compounds for treating pruritic conditions

Publications (1)

Publication Number Publication Date
PL3286198T3 true PL3286198T3 (pl) 2021-09-06

Family

ID=57144302

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16784019T PL3286198T3 (pl) 2015-04-23 2016-04-22 Związki do leczenia stanów świądowych

Country Status (15)

Country Link
US (1) US9624233B2 (pl)
EP (1) EP3286198B1 (pl)
JP (1) JP6744327B2 (pl)
AU (1) AU2016252892B2 (pl)
CA (1) CA2981625C (pl)
CY (1) CY1124163T1 (pl)
DK (1) DK3286198T3 (pl)
ES (1) ES2867799T3 (pl)
HR (1) HRP20210606T1 (pl)
HU (1) HUE054399T2 (pl)
LT (1) LT3286198T (pl)
PL (1) PL3286198T3 (pl)
PT (1) PT3286198T (pl)
SI (1) SI3286198T1 (pl)
WO (1) WO2016172613A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111116597A (zh) * 2018-10-31 2020-05-08 扬子江药业集团江苏紫龙药业有限公司 一种纳布啡游离碱的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477456A (en) * 1981-07-02 1984-10-16 E. I. Du Pont De Nemours And Company Octahydro-4A,7-ethano- and -etheno-benzofuro[3,2-e]isoquinoline derivatives having analgesic, narcotic antagonist and anorexigenic properties
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
EP3064503A1 (en) * 2007-03-29 2016-09-07 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof

Also Published As

Publication number Publication date
JP2018513174A (ja) 2018-05-24
EP3286198B1 (en) 2021-02-24
CA2981625C (en) 2023-05-23
AU2016252892B2 (en) 2019-05-02
US20160311832A1 (en) 2016-10-27
CY1124163T1 (el) 2022-05-27
CA2981625A1 (en) 2016-10-27
PT3286198T (pt) 2021-04-26
EP3286198A1 (en) 2018-02-28
EP3286198A4 (en) 2018-09-26
AU2016252892A1 (en) 2017-10-26
US9624233B2 (en) 2017-04-18
HRP20210606T1 (hr) 2021-05-28
LT3286198T (lt) 2021-07-12
SI3286198T1 (sl) 2021-08-31
DK3286198T3 (da) 2021-05-03
WO2016172613A1 (en) 2016-10-27
HUE054399T2 (hu) 2021-09-28
ES2867799T3 (es) 2021-10-20
JP6744327B2 (ja) 2020-08-19

Similar Documents

Publication Publication Date Title
HK1244217A1 (zh) 用於治療蛋白質病的方法
HK1245804A1 (zh) 用於治療pvns的抗csf1r抗體
HK1248133A1 (zh) 治療神經母細胞瘤的方法
HK1251965A1 (zh) 用於治療癲癇的方法
HK1255871A1 (zh) 用於治療骨髓瘤的賽度替尼
HK1250649A1 (zh) 用於治療白血病的抗-s100a8
IL249475A0 (en) Methods for treating itching
HK1249901B (zh) 用於抑制ror-gamma-t的化合物
HK1255481A1 (zh) 用於治療hcv的方法
EP3283115C0 (en) COMPOSITIONS FOR THE TREATMENT OF AUTISM
EP3369419C0 (en) COMPOSITION FOR THE TREATMENT OF DIABETES
PT3250218T (pt) Péptido natkide para o tratamento da obesidade
EP3130586A4 (en) Process for treating homoserine-based compound
HK1259615A1 (zh) 谷氨酸-高z元素化合物治療癌症
HUE054399T2 (hu) Vegyületek viszketéses állapotok kezelésére
HK1254378A1 (zh) [(2-乙氧基-5-反式-1-丙烯-1-基)-苯氧基]封端化合物
IL249616A0 (en) Methods for treating inflammation
EP3246432A4 (en) Method for treating parts
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201709559D0 (en) Compounds for treating lupus
GB201508453D0 (en) Compounds
GB201505670D0 (en) Compounds
GB201505674D0 (en) Compounds